knowledge -WSS

knowledge

author：comprehensive 2025-09-28 23:50:05 - browse：212

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： 'Little Tech' descents on D.C., wanting a say in how AI is regulated

WSS

Eli Lilly’s Zepbound improved liver scarring in mid

A new initiative will help leaders fight the next pandemic

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Structure Therapeutics oral GLP

US soldier in North Korean custody after crossing DMZ line

Manchin plays down potential 3rd

explore

knowledge

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

Twill hunts for pharma partner to market its depression app

Activists slam private health insurers over coverage restrictions

A look at other Americans who have crossed into North Korea over the years

Medical records are filled with copy

UK homeowners get some respite as inflation falls by more than anticipated to a 15

At least 13 dead in Texas as scorching temps continue

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Manchin plays down potential 3rd

entertainment

Congress needs to close a vaccine

UnitedHealth CEO's Medicaid comments send insurer stocks diving

A new initiative will help leaders fight the next pandemic

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

BridgeBio heart drug succeeds in pivotal study

Finland to offer bird flu vaccine to select groups of people, a possible global first

focus

focus

hotspot

explore